Related references
Note: Only part of the references are listed.Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants
Onofrio Laselva et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Rescue of multiple class II CFTR mutations by elexacaftor plus tezacaftor plus ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator
Onofrio Laselva et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis
Anh-Thu N. Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Mutant CFTR Drives TWIST1 mediated epithelial-mesenchymal transition
Margarida C. Quaresma et al.
CELL DEATH & DISEASE (2020)
Extent of rescue of F508de1-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients
Arthur Kmit et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del?CFTR
Yukiko Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
Harry G. M. Heijerman et al.
LANCET (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis
Harriet Corvol et al.
FRONTIERS IN PHARMACOLOGY (2018)
Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
Anita Balazs et al.
FRONTIERS IN PHARMACOLOGY (2018)
The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9
Carol A. Bertrand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
Miqueias Lopes-Pacheco
FRONTIERS IN PHARMACOLOGY (2016)
Progress in therapies for cystic fibrosis
Kris De Boeck et al.
LANCET RESPIRATORY MEDICINE (2016)
Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients
M. D. Amaral
JOURNAL OF INTERNAL MEDICINE (2015)
Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis
Melissa R. Miller et al.
JOURNAL OF PEDIATRICS (2015)
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
Scott C. Bell et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Cystic fibrosis genetics: from molecular understanding to clinical application
Garry R. Cutting
NATURE REVIEWS GENETICS (2015)
Disrupted tight junctions in the small intestine of cystic fibrosis mice
Robert C. De Lisle
CELL AND TISSUE RESEARCH (2014)
Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities
Weili Li et al.
HUMAN GENETICS (2014)
Differential contribution of SLC26A9 to Cl- conductance in polarized and non-polarized epithelial cells
Jiraporn Ousingsawat et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation
Pinelopi Anagnostopoulou et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis
Lei Sun et al.
NATURE GENETICS (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
SLC26A9 Stimulates CFTR Expression and Function in Human Bronchial Cell Lines
Martine Avella et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers
Pierre LeSimple et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia
Carol A. Bertrand et al.
JOURNAL OF GENERAL PHYSIOLOGY (2009)
The solute carrier 26 family of proteins in epithelial ion transport
Michael R. Dorwart et al.
PHYSIOLOGY (2008)
The SLC26 gene family of multifunctional anion exchangers
DB Mount et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
CFTR and bicarbonate secretion to epithelial cells
MJ Hug et al.
NEWS IN PHYSIOLOGICAL SCIENCES (2003)
Share Paper
